Last Updated: May 11, 2026

Details for Patent: 5,510,383

Name: Drug Patent Intelligence for US Patent 5510383
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,510,383

Title:	Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
Abstract:	Disclosed is the use of cloprostenol, fluprostenol, and their pharmaceutically acceptable salts and esters for the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic compositions comprising said compounds.
Inventor(s):	John E. Bishop, Louis DeSantis, Jr., Verney L. Sallee
Assignee:	Alcon Research LLC
Application Number:	US08/101,598
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 5,510,383

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 5,510,383

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1514548	⤷ Start Trial	C300671	Netherlands	⤷ Start Trial
European Patent Office	1514548	⤷ Start Trial	PA2014029	Lithuania	⤷ Start Trial
European Patent Office	1514548	⤷ Start Trial	CA 2014 00038	Denmark	⤷ Start Trial
European Patent Office	1920764	⤷ Start Trial	CA 2012 00030	Denmark	⤷ Start Trial
European Patent Office	1920764	⤷ Start Trial	92058	Luxembourg	⤷ Start Trial
European Patent Office	1920764	⤷ Start Trial	PA2012017	Lithuania	⤷ Start Trial
European Patent Office	1920764	⤷ Start Trial	C01920764/01	Switzerland	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.